IMU Biosciences nabs $53M funding round to ‘decode’ the immune system
British medtech startup IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune system analysis from analogue to “high defini...
British medtech startup IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune system analysis from analogue to “high definition.”